ERBB2 and neoplasm: In ERBB2-positive gastric cancers, the miR-1296-5p expression is more suppressed in a majority of metastatic lymph node tissues compared to non-metastatic gastric cancer samples, suggesting that miR-1296-5p might play a role of tumor metastasis suppressor in ERBB2-positive gastric cancer.